To the Editor:

In young children unable to perform reliable and reproducible spirometry, non-cooperative lung function techniques are necessary to measure bronchial hyperreactivity (BHR) during bronchial challenge \[[@C1]\]. Measuring the decrease in transcutaneous partial pressure of oxygen (*P*~tcO~2~~) is a robust technique that detects increased ventilation--perfusion mismatch during bronchial challenge \[[@C2]\] in preschool and school-aged children \[[@C3]--[@C5]\], and a 20% decrease in *P*~tcO~2~~ correlates to a 20% forced expiratory volume in 1 s (FEV~1~) decrease in children aged 6--14 years \[[@C3]\] and in adults (with correlation to arterial oxygen tension) \[[@C6]\]. When neither spirometry nor *P*~tcO~2~~ is available, other BHR outcomes can be measured such as wheezing that appears for mean±[sd]{.smallcaps} decreases of −44.7±14.5% in FEV~1~ and −6.3±2.7% in transcutaneous saturation of oxygen (*S*~pO~2~~) \[[@C7]\]. Respiratory resistances are easy to measure \[[@C8]--[@C10]\] but the relevant threshold for BHR is not yet defined and an at least 35% increase variably correlates with *P*~tcO~2~~ changes \[[@C8], [@C11]\]. First, we aimed to better study two alternative outcomes (*i.e.* interrupter resistance (*R*~int~) and *S*~pO~2~~) and challenge the current recommendations \[[@C1]\] of measuring resistance during inspiration (as opposed to measuring during expiration for reversibility testing \[[@C12]\]), because the physiological expiratory glottis closure can be enhanced during bronchial challenge-induced bronchoconstriction and specific extrathoracic airway reactivity to bronchoconstrictor agents can occur. Second, we wished to evaluate the proposed thresholds for *R*~int~ and *S*~pO~2~~ (+35% and −5% baseline, respectively), as only a 3% decrease is considered to be significant in sleep studies and a mean±[sd]{.smallcaps} *S*~pO~2~~ decrease of −5.2±3.1% corresponds to a much larger than 20% decrease in FEV~1~ in 5--8-year-old asthmatic children (−33.3±7.4% decrease in FEV~1~) \[[@C13]\].

Between June 2013 and September 2014, we prospectively and consecutively included 28 children unable to correctly perform a spirometry who were referred to our lung function laboratory for a methacholine challenge. Children had to be free of treatment and acute respiratory symptoms for 3 weeks. Chest auscultation had to be normal.

At each step of the bronchial challenge, inspiratory and expiratory series of at least five correct interruptions (*R*~int~insp~~ and *R*~int~exp~~, respectively) were performed in random order (but always in the same order with each specific child) using a MicroRint device (Micro Medical, Rochester, UK). *P*~tcO~2~~ and *S*~pO~2~~ were recorded throughout the test as previously described \[[@C8]\] using a Tina CombiM (Radiometer, Bronshoj, Denmark). Lung function was checked to be within the range of normal at baseline and assessed after inhalation of saline (diluent) to obtain the reference for changes during the challenge. Doubling doses of methacholine were inhaled, using the dosimeter method, every 5 min \[[@C8]\], from 50 µg up to a cumulative dose of 800 µg. The test ended when *P*~tcO~2~~ had fallen by 20% or more (PD~20~*P*~tcO~2~~), the child had respiratory symptoms or the maximal dose of methacholine was reached. The study was approved by the Institutional Review Board of the French learned society for respiratory medicine (Société de Pneumologie de Langue Française) (CEPRO 2013-015) and the children\'s parents gave informed consent to the study.

Repeated measurements in children were compared using paired the Wilcoxon signed-rank test. Comparisons of lung function indices between groups of children (responsive and nonresponsive) were performed using the Fisher exact test.

27 (13 girls and 14 boys, median (range) age 5.5 (4.2--8.1) years) children completed all measurements during the bronchial challenge. One child pulled off the *P*~tcO~2~~ electrode before the end of the test and was, therefore, excluded. 25 children were referred for chronic cough (started at a median age of 2.7 (0.3--8) years), one for suspicion of wheezing and one for dyspnoea upon exertion.

At baseline, *R*~int~exp~~ was higher than *R*~int~insp~~ (mean 0.81 *versus* 0.60 kPa·s·L^−1^, with a mean difference of −0.21 kPa·s·L^−1^ (95% CI −0.26-- −0.16 kPa·s·L^−1^); p\<0.0001), but within the range of normal for all children \[[@C14]\]. At the time of interruption, expiratory airflow was lower than inspiratory airflow throughout the test (*e.g.* at baseline: 0.30 and 0.39 L·s^−1^, respectively; p\<0.002). 20 children reached the PD~20~*P*~tcO~2~~ at a median cumulative dose of methacholine of 100 µg (50--400 µg) (responsive children) without any respiratory symptoms. 14 responsive children had an at least 35% *R*~int~insp~~ increase (PD~35~*R*~int~insp~~) during the methacholine challenge whereas six responsive children and all the nonresponsive children did not reach PD~35~*R*~int~insp~~ (p\<0.002). Using *R*~int~exp~~, there was no association between PD~35~*R*~int~exp~~ at any time during the test and the presence of BHR (p=1). Therefore, sensitivity and specificity were 70% (95% CI 48--85%) and 100% (95% CI 65--100%), respectively, for *R*~int~insp~~, and 50% (95% CI 30--70%) and 57% (95% CI 25--84%), respectively, for *R*~int~exp~~ to detect BHR at or before PD~20~*P*~tcO~2~~. Taking into account all cases of discordance between *R*~int~ and *P*~tcO~2~~ changes (significance of the changes at each test step), the number of discordant *R*~int~exp~~ values (n=19) was higher than that of *R*~int~insp~~ values (n=11) ([table 1](#TB1){ref-type="table"}). For both *R*~int~ measurements, the discordances with *P*~tcO~2~~ changes were equally due to PD~35~*R*~int~ reached before PD~20~*P*~tcO~2~~ or to a less than 35% *R*~int~ increase at PD~20~*P*~tcO~2~~. In the majority of cases, *R*~int~insp~~ steadily increased during the bronchial challenge, whereas *R*~int~exp~~ had a more irregular pattern of changes and the final change in *R*~int~exp~~ was smaller than that of *R*~int~insp~~ in all the study children ([table 1](#TB1){ref-type="table"}). All the children (n=11) whose *R*~int~insp~~ increased by 35% or more without a concomitant 20% *P*~tcO~2~~ decrease were eventually responsive, whereas three of the nine children with early PD~35~*R*~int~exp~~ remained nonresponsive throughout the test (three *R*~int~exp~~ false positives). Finally, at PD~20~*P*~tcO~2~~, *R*~int~insp~~ and *R*~int~exp~~ would not have diagnosed BHR in six cases and 10 cases, respectively (false negative), representing 12 children, among whom only two had a 5% decrease in *S*~pO~2~~ at the same time. TABLE 1Changes and discordances during methacholine challenge between interrupter resistance (*R*~int~) and transcutaneous partial pressure of oxygen (*P*~tcO~2~~)**Responsive childrenNonresponsive childrenSubjects n**207**Changes in *P***~**tcO**~**2**~~ **%**−25.4±4.8−13.4±8.4**Changes *R***~**int**~**insp**~~ **%**+49.1±29.6+13.2±11.4**Change *R***~**int**~**exp**~~ **%**+34.3±27.9+8.8±17.4**Discordance between *R***~**int**~**insp**~~ **and *P***~**tcO**~**2**~~ **n (%, 95% CI)**11 (55, 34--74)0 (0, 0--35) *R*~int~ increase \<35% at PD~20~*P*~tcO~2~~ n6 *R*~int~ increase ≥35% before PD~20~*P*~tcO~2~~ n5**Discordance between PD**~**35**~***R***~**int**~**insp**~~**+*S***~**pO**~**2,3%**~~\
**and *P***~**tcO**~**2**~~ **n**60**Discordance between *R***~**int**~**exp**~~ **and *P***~**tcO**~**2**~~ **n (%, 95% CI)**16 (80, 58--92)3 (42, 16--75) *R*~int~ increase \<35% at PD~20~*P*~tcO~2~~ n100 *R*~int~ increase ≥35% before PD~20~*P*~tcO~2~~ n63**Discordance between PD**~**35**~***R***~**int**~**exp**~~**+ *S***~**pO**~**2,3%**~~\
**and *P***~**tcO**~**2**~~ **n**93[^1]

Using *R*~int~insp~~ changes expressed as percentage of predicted rather than percentage of baseline would have changed the significance of a *R*~int~insp~~ increase in two out of 81 *R*~int~insp~~ measurements performed after methacholine inhalation in all study children. These two measurements occurred after the first dose of methacholine in two discordant children (PD~35~*R*~int~insp~~ reached before PD~20~*P*~tcO~2~~) in whom, after the second methacholine inhalation, both changes (% predicted and % baseline) corresponded but remained discordant with that of PD~20~*P*~tcO~2~~. Therefore, the analysis of the concordance between *R*~int~insp~~ and PD~20~*P*~tcO~2~~ changes would not change using percentage predicted or percentage baseline.

If the threshold for *R*~int~ were increased by up to 40%, discordance between *P*~tcO~2~~ and *R*~int~insp~~ would remain the same, whereas discordance with *R*~int~exp~~ would decrease from 19 to 15 cases (still with two false positives). If a 3% decrease in *S*~pO~2~~ were the threshold, 15 out of the 20 responsive children would have reached this threshold at PD~20~*P*~tcO~2~~ (none before PD~20~*P*~tcO~2~~), while none of the nonresponsive children would have reached it at any step of the test (p\<0.001). Moreover, using PD~35~*R*~int~insp~~ or a 3% decrease in *S*~pO~2~~ as a composite criterion for bronchial responsiveness, only one responsive child would not have been diagnosed as responsive at PD~20~*P*~tcO~2~~ (sensitivity 95%, 95% CI 76--99%) *versus* six false negatives with PD~35~*R*~int~insp~~ or −5% *S*~pO~2~~ criterion.

Our results do not support a universal physiological mechanism to explain discrepancies between *R*~int~ and *P*~tcO~2~~ measurements during bronchial challenge in young children. The lack of *R*~int~ increase in responsive children could reflect an early ventilation--perfusion mismatch with no central airway obstruction but the better concordance between *P*~tcO~2~~ and *R*~int~insp~~ over *R*~int~exp~~ remains unexplained. The early reactivity in *R*~int~ (before PD~20~*P*~tcO~2~~) might be due to glottis changes but we failed to demonstrate any specific recurring patterns of changes of airflow at interruption or of difference between *R*~int~insp~~ and *R*~int~exp~~ explaining the discrepancies recorded.

To challenge the proposed threshold for *R*~int~ \[[@C1]\], we switched from a 35% to a 40% increase and the total number of discordances decreased only for *R*~int~exp~~ although they remained higher than that of *R*~int~insp~~. However, as a *R*~int~ device may measure only *R*~int~exp~~, the threshold of 40% may be useful to implement. In children with no *R*~int~ increase at PD~20~*P*~tcO~2~~, a 3% decrease in *S*~pO~2~~ better detected BHR than a 5% decrease. The better accuracy of a −3% *S*~pO~2~~ threshold, over a −5% threshold, increases the safety of associating *R*~int~ and *S*~pO~2~~ measurements when *P*~tcO~2~~ is not available.

In conclusion, *R*~int~insp~~ better detects BHR than *R*~int~exp~~ and might better match PD~20~*P*~tcO~2~~ changes. Until larger studies confirm these first results, it is reasonable to stick to the proposal of favouring measurement of *R*~int~insp~~ rather than *R*~int~exp~~ during methacholine challenge. Our findings strengthen the recommendation to associate bronchial reactivity outcomes when *P*~tcO~2~~ measurement is not available. Finally, the combination of a 35% *R*~int~insp~~ increase or a 3% *S*~pO~2~~ decrease might be a useful criterion for detecting BHR with respect to *P*~tcO~2~~ changes.
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[^1]: Data are presented as mean±[sd]{.smallcaps} percentage of post-diluent values unless otherwise stated. Changes are at the provocative dose of methacholine causing a 20% decrease in *P*~tcO~2~~ (PD~20~*P*~tcO~2~~) in responsive children and at the last dose of methacholine in nonresponsive children. Discordances between *R*~int~ and *P*~tcO~2~~ changes were assessed at every steps of the test. *R*~int~ changes are more or less than 35% increase from the post-diluent value (PD~35~*R*~int~). *R*~int~insp~~: inspiratory interrupter resistance; *R*~int~exp~~: expiratory interrupter resistance; PD~35~*R*~int~insp~~: provocative dose of methacholine causing a 35% decrease in *R*~int~insp~~; *S*~pO~2,3%~~: at least 3% decrease in transcutaneous saturation of oxygen from the post-diluent value; PD~35~*R*~int~exp~~: provocative dose of methacholine causing a 35% decrease in *R*~int~exp~~.
